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ABSTRACT A cins e, high-afnity Drosophila
serotonin (5-hydroxytryptamine; SHT) transporter cDNA, de-
noted dSERT1, was isolated and characterized in oocytes.
dSERT1 shows little transport ofother monoamnes and is Na+
and Cl- dependent. Sequence anlsis indicates 12 putative
tranmbrane domains and strong homologies (%50%)
among dSERT1 and mmi SHT, norepinephrine, and
transporters. Interest y, the ph ica
propertiesaofdSERT1, iuding sensitivit to antidepressants,
are more similar to those of ammalian cateolie trans-
prers than to m a SST tnsporters. Two-electrode
voIWe-dmp analysis nted H-induced, voltage-
dpendent currents. Clog and characterization of dSERT1
adds ificantly to our knowledge of the diversity of 5HT
transporters with regard topi sequence, pharmacolog-
ical profile, and permeation properties.
One mechanism for the regulation of synaptic activity is
through removal of neurotransmitter from the synaptic cleft
via high-affinity transporters located on neuronal and glial
plasma membranes. By slowing the removal of neurotrans-
mitter from the cleft, inhibition of these transporters can
effectively increase the duration of neurotransmitter action
on postsynaptic receptors. Recent cloning studies indicate
that neurotransmitter transporters consist of two distinct
multigene superfamilies. The members of one family are
dependent on sodium and chloride for full activity (Na+/Cl-
transporters) and their substrates include -y-aminobutyric
acid (GABA) and glycine (1-7), the monoamine neurotrans-
mitters (8-14), proline (15), taurine (16), betaine (17), and
creatine (18). A second superfamily consists of transport
proteins that require sodium and potassium for fills activity
(Na+/K+ transporters) and includes the transporters for
glutamate (19-21) and certain neutral amino acids (22, 23).
Although there is no discernible sequence homology between
these two superfamilies, they do share several important
features: (i) they transport their substrates with high affinity;
(ii) their activity is dependent on membrane potential; and
(iii) they are predicted to be integral membrane proteins with
multiple transmembrane domaifs ranging from 6 to 10 for the
Na+/K+ transporters to 12 for the Na+/Cl- transporters.
Although the neurotransmitter transporters cloned to date
have all been mammalian, histochemical experiments suggest
that members ofboth of these gene superfamilies are present
in a variety of phyla, including crustaceans (24), nematodes
(25), and insects (26). The fruitfly Drosophila is a particularly
useful model for studying neurotransmitter molecular biol-
ogy, since its nervous system is well-characterized at the
anatomical, neurochemical, and genetic levels. Drosophila
use GABA, acetylcholine, glutamate, dopamine, and sero-
tonin (5-hydroxytryptamine; 5HT) as neurotransmitters and
also may use such diverse substances as histamine, octo-
pamine, and tyramine (reviewed in ref. 27). It is likely that
transporters for all of these substances exist in the Drosoph-
ila nervous system. In fact, in vivo uptake mechanisms have
been suggested to be responsible for 5HT accumulation in
Drosophila mutants lacking the gene encoding dopa decar-
boxylase (Ddc) (28).
We have used a PCR-based cloning strategy to isolate a
Drosophila 5HT transporter (termed dSERT1) that is homol-
ogous to the mammalian monoamine transporters, as well as
to other mammalian members of the Na+/Cl- superfamily.
We show that dSERT1 possesses a number of functional
properties of this family, including a dependence on sodium
and chloride, a high affinity for 5HT, and electrogenicity. We
also observe that dSERT1 is cocaine sensitive, possessing an
unusual pharmacological profile with properties more similar
to mammalian catecholamine transporters than to indole-
amine transporters, and has electrogenic properties similar to
the mammalian GABA transporteri
EXPERIMENTAL PROCEDURES
PCR. Degenerate oligonucleotide primers corresponding
to two highly conserved amino acid regions near the first
(NVWRFPY) and sixth (DAATQIF) transmembrane do-
mains of the rat GABA transporter (1) were designed using
Drosophila codon usage. The primers consisted of a 144-fold
degenerate upstream (sense) primer corresponding to bases
345-363 ofGAT1 with the sequence (5' to 3') GAGCTC GTC
GAC AA(TC) GT(GCT) TGG (CA)G(GCTA) TTC CC(CAG)
TA and a 48-fold degenerate downstream (antisense) primer
corresponding to bases 1008-1026 of GAT1 with the se-
quence GGG CCC TCT AGA AA(GA) ATC TG(GC) GT-
(GAC) GC(GA) GC(AG) TC. (The underlined portions of
these sequences indicate the addition of 5' restriction sites for
cloning purposes.) With these primers, the PCR will generate
a 683-bp product from GAT1 mRNA and a 699-bp product
from NET1 mRNA. The amplification protocol consisted of
1 min at 940C, 2 min at 650C, and 2 min at 720C for 25-30
cycles. Gel electrophoresis indicated a band of =700 bp,
which was subcloned into pBluescript SK(-).
Isolion and Characterization ofdSERTl cDNA Clone. The
700-bp product was used in a PCR to synthesize a 32P-labeled
probe. This probe was used to screen 1 x 106 phage recom-
binants from the Drosophila head cDNA library in AEXLX
(29). After overnight hybridization at 420C [6x SSPE (lx
SSPE = 0.18 M NaCl/10 mM phosphate, pH 7.4/1 mM
EDTA)/35% formamidel, the filters were washed at a final
stringency of 500( in 2x standard saline citrate (SSC)/0.1%
SDS. Positive clones were rescued and the insert ofone ofthe
three positive clones was subcloned in pGEM-7Zf(+)
(Promega) for sequencing and in -iitro transcription.
Abbreviations: GABA, y-aminobutyric acid; 5HT, serotonin.
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Xenopus Oocyte Expression and Transport Assays. dSERT1
linearized with Cla I was used as template for an in vitro
transcription reaction (Ambion MegaScript kit, Ambion,
Austin, TX). To obtain expression levels large enough to
measure the transporter-associated currents, we used a pre-
viously described PCR-based procedure (30). Methods for
oocyte preparation, injection, flux assays, and electrophys-
iology are described elsewhere (31).
Northern Blot Analysis. Twenty micrograms of total RNA
from Drosophila head, body, and embryo was separated on
a 1% formaldehyde agarose gel and transferred to a nylon
membrane (GeneScreenPlus, DuPont/NEN) and probed
with a 506-bp fragment of dSERT1 (48 bp of the C terminus
and 468 bp of 3' untranslated region). The membrane was
hybridized overnight at 420C (50%o formamide/10% dextran
sulfate/i M NaCl/1% SDS), washed at 650C for 15 min (0.1x
SSC/1% SDS), and exposed to film for 24 h at -70'C.
RESULTS
Identification ofdSERT1 as a 5HT Transporter. Degenerate
oligonucleotides corresponding to conserved portions of pu-
tative transmembrane regions 1 and 7 of the Na+/Cl- trans-
porter superfamily were used to amplify aliquots of a Dro-
sophila head cDNA library. An expected product of =700 bp
was observed, and DNA sequencing confirmed that this PCR
product encoded a member of the Na+/Cl- superfamily. The
insert was used to isolate a full-length cDNA from the same
library. Three clones were plaque purified under high-
stringency hybridization conditions and one (clone 39a) was
chosen for sequencing and expression characterization.
mRNA synthesized from this clone was expressed in Xeno-
pus oocytes and screened for potential substrates (Fig. 1).
Oocytes injected with clone 39a mRNA transported [3H]5HT
at 5-fold higher levels than uninjected oocytes when incu-
bated for 30 min in 760 nM [3H]5HT. Uptake of [3H]GABA,
[3H]glutamate, [3H]histamine, [3H]dopamine, and [3H]nore-
pinephrine was not significantly over the background levels.
This indicates that clone 39a encodes a 5HT transporter,
which we have designated dSERT1.
Sequencing and Molecular Characterization of dSERT1.
Sequencing of dSERT1 revealed a 2461-bp insert with an
open reading frame of 1743 bases. The proposed initiator
ATG, at base 109, occurs within a reasonable match to the
consensus translation initiation site (32). The open reading
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FIG. 1. Transport of various neurotransmitters by dSERT1 ex-
pressed in Xenopus oocytes. Final concentrations of the listed
neurotransmitters were as follows: 760 nM [3H]5HT, 260 nM
[3H]GABA, 370 nM [3H]glutamate, 3.8 ,uM [3H]histamine, 800 nM
[3H]dopamine, 1.3 ,&M [3H]norepinephrine. Each point in these
experiments is the mean ± SEM of at least four oocytes.
frame encodes a protein of 581 amino acids with a predicted
mass of 67 kDa. This sequence does not contain an in-frame
stop codon or an alternative initiation codon in the 108-bp 5'
untranslated region of dSERT1. It is possible that there is an
upstream initiation codon in the complete mRNA and that the
present cDNA encodes a functional truncated protein. Hy-
dropathy analysis (33) predicts 12 putative membrane-
spanning domains, indicating a membrane topology similar to
that proposed for all members of the Na+/Cl- transporter
superfamily (1). There is one potential N-linked glycosylation
site, located in the large extracellular loop between the third
and fourth transmembrane regions. The primary amino acid
sequence predicts four potential protein kinase C phosphor-
ylation consensus sites: two in putative extracellular regions
and two in the intracellular N terminus (Thr-3 and Thr-4).
Comparison of the predicted amino acid sequence to those of
the mammalian 5HT transporters and to the human norepi-
nephrine transporter reveals considerable homology (Fig. 2):
52% and 53% amino acid identity to the rat and human 5HT
transporters, respectively (13, 34); 51% identity to NET1 (8);
and 48% identity to the rat/bovine dopamine transporters
(9-12). The percentage identity is only 39-43% between
dSERT1 and the transporters for GABA (1), glycine (5),
proline (15), and taurine (16). Comparison of the dSERT1
sequence to sequences in the Genbank data base using the
BLAST program revealed no homologous sequences other
than members of the Na+/Cl- transporter family.
Northern Blot Analysis. A Northern blot revealed a strong
signal at -3.3 kb in total RNA from adult Drosophila heads,
but no detectable signal with RNA from adult Drosophila
bodies or embryos with an 18-h exposure (data not shown).
Thus, dSERT1 is predominantly expressed in structures
associated with the head, most likely neurons and/or glia of
the cephalic nervous system (35).
Transport Studies. Oocytes injected with dSERT1 mRNA
exhibit an ion-dependent, high-affinity 5HT uptake system
that saturates with increasing 5HT concentration (Fig. 3).
Eadie-Hofstee analysis (Fig. 3 Inset) demonstrates a Km of
637 ± 100 nM (mean ± SEM of four experiments), which is
similar to the Km values determined for the cloned and
endogenous mammalian 5HT transporters (13, 14, 34, 36-39).
High-affinity transport of SHT by dSERT1 is dependent on
extracellular Na+ and Cl-, a hallmark of this transporter
family (40). Substitution of Na+ with either Li+ or choline
reduced transport by -95%, while substitution of Cl- with
nitrate or acetate inhibited uptake by 85-91% (data not
shown).
Pharmacological Specificity. Drug sensitivity of dSERT1
was assessed by compounds known to inhibit mammalian
biogenic amine transport (Table 1). The antidepressants
fluoxetine and clomipramine were 6- to 71-fold lower in
potency at dSERT1 than at the mammalian 5HT transporters.
By contrast, mazindol and nomifensine, which are strong
inhibitors of NET1 and DAT1, but are less effective at the
mammalian 5HT transporter, were potent inhibitors of
dSERT1. Thus, with respect to this group of antidepressants,
dSERT1 has a pharmacological profile more similar to the
mammalian catecholamine transporters than to the mamma-
lian 5HT transporters. This characteristic is further under-
scored by the observation that dSERT1 is -5-fold more
sensitive to cocaine, a potent inhibitor of mammalian dopa-
mine and norepinephrine uptake, than are the mammalian
5HT transporters. However, the sensitivity of dSERT1 to
amphetamine is closer to that observed for the rat and human
5HT transporters than to the human norepinephrine trans-
porter, possibly because amphetamine is a substrate for 5HT
transporters. Therefore, the pharmacological profile of
dSERT1 represents a mixture of those seen for the mamma-
lian biogenic amine transporters. It is important to note,
however, that the specificity of dSERT1 for 5HT as a
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substrate is quite high; unlabeled 5HT is 158- to 479-fold more
potent than epinephrine, dopamine, and norepinephrine in
reducing [3H}5HT uptake by dSERT1-injected oocytes. This
finding corroborates the results of uptake experiments with
labeled catecholamines (Fig. 1) and further establishes that
dSERT1 is indeed a 5HT transporter rather than a substrate-
ambiguous catecholamine transporter.
We searched for additional organic substrates of dSERT1
by examining their ability to decrease transport of 100 nM
[3H]5HT. Tryptamine, which is a substrate for the endoge-
nous platelet 5HT transporter (41), was the most effective
inhibitor tested in this series, reducing accumulation of
[3H]5HT to 27% ± 5% ofcontrol values (mean ± SEM) at 200
,uM. Tryptophan, a precursor of tryptamine and 5HT, did not
decrease SHT transport (105% +- 5.4%) at 200 ,uM, nor did the
metabolite of5HT, 5-hydroxyindoleacetic acid (100% ± 13%)
at 100 uM. Tyramine, a putative insect neurotransmitter,
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reduced uptake to 61% + 7% of control values at 200 pM.
Octopamine and histamine, two other putative insect neuro-
transmitters, had little or no effect on [3H]5HT transport at
200 AM (82% ± 15% and 95% ± 15%, respectively). For
comparison, nonradioactive 5HT (acting as a diluent) re-
duced transport of[3H]5HT by 50%o at 100 nM, as expected.
Ion and Voltage ence of Transport-Assocated Cur-
rents. By measurements in individual voltage-clamped
oocytes, we found that uptake of [3H]5HT is voltage depen-
dent; for example, in one set of measurements over a 5-min
time period, uptake increased from 34 ± 16 fmol per oocyte
to 90 ± 27 fmol per oocyte between -40 and -80 mV (data
not shown). This result prompted us to ask whether dSERT1
is an electrogenic transporter. We used two-electrode volt-
age-clamp analysis to characterize 5HT-induced currents.
When oocytes expressing dSERT1 were exposed to SHT
concentrations of 0.1-30 ,uM, distinct inward currents could
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FIG. 3. Kinetics of [3H]5HT uptake. Data for these experiments
are representative offour separate experiments and each point is the
mean ± SEM of seven determinations. (Inset) Eadie-Hofstee plot of
initial velocity data.
be measured (Fig. 4A). At saturating concentrations of 5HT
and membrane holding potentials of -60 or -80 mV, the
largest currents induced were =300 nA. The magnitude ofthe
5HT-induced inward currents remained essentially constant
during 5HT application times as long as 5 min (n = 11). The
5HT-induced currents were observed in dSERT1-expressing
oocytes from three separate oocyte batches but were not seen
in uninjected oocytes (n = 9) or in control oocytes injected
with mRNA encoding the rat brain GABA transporter GAT1
(n = 6). Application of 10 ,uM dopamine, norepinephrine, and
epinephrine did not evoke measurable currents (data not
shown), further indicating the specificity ofdSERT1 for 5HT.
Fig. 4B shows the current-voltage relationship for the
5HT-induced current and the effect of ion substitution on
these currents. For an oocyte superfused with 5 ,uM 5HT in
ND96 medium, the 5HT-induced current increased more than
linearly between +40 and -100 mV. Between -40 and -80
mV, there was a 2.4-fold increase in the amount of transport-
associated current, similar to the voltage dependence of
[3H]5HT uptake. When either Na+ or Cl- is eliminated from
the superfusion medium, the 5HT-induced currents are too
small for systematic current-voltage analysis.
DISCUSSION
When expressed in Xenopus oocytes, dSERT1 reconstitutes
a high-affinity, cocaine-sensitive, Na+- and Cl--dependent
5HT uptake system. The apparent Km for 5HT of dSERT1
(637 nM) is comparable to the range of values determined for
the cloned mammalian 5HT transporters (13, 14, 34) as well
as for native mammalian 5HT transporters (36-39). It has a
low affinity for norepinephrine, dopamine, and epinephrine
and does not transport other neurotransmitters found in the
Drosophila nervous system (e.g., glutamate, GABA, dopa-
mine, or histamine). Although the amino acid sequence of
dSERT1 shows various degrees of homology with all known
members of the Na+/Cl- transporter superfamily, it is most
closely related to the mammalian 5HT, norepinephrine, and
dopamine transporters. The observation that dSERT1 has
about the same degree of structural relatedness to the three
mammalian monoamine transporters correlates with its un-
usual functional properties. Its sensitivity to antidepressants
more closely resembles that ofNET1 and DAT1 than that of
the mammalian 5HT transporter. Similarly, dSERT1 is more
sensitive to cocaine than is the mammalian 5HT transporter.
By contrast, the sensitivity of dSERT1 to amphetamine is
more similar to that of the mammalian 5HT transporters than
to that of NET1 and DAT1. Thus, although dSERT1 has a
high substrate specificity for 5HT, it exhibits a pharmaco-
logical profile that shares features of both mammalian in-
doleamine and catecholamine transporters.
External application of 5HT to dSERT1-injected oocytes
induces an inward current that is associated with 5HT
uptake. This indicates that the transporter encoded by
dSERT1 is electrogenic and that the net charge movement
associated with transport is inward. Furthermore, (i) the
substrate-induced current does not inactivate, even with
extended substrate application times; (ii) the substrate-
induced current has an absolute requirement for external
Na+; (iii) the substrate-induced current is strongly dependent
on external Cl-; (iv) the current-voltage relationship shows
Table 1. Comparison of IC50 values
Norepinephrine
5HT transporters, nM transporter, nM Dopamine
dSERT1 5HTT* hSERTt NET1t transporter, nM
Inhibitor (Drosophila) (rat) (human) (human) DAT§ (rat)
Mazindol 27 548 NA 1.4 27
Nomifensine 44 NA 100 7.7 118
5HT 165 NA NA >10,000 >10,000
Cocaine 184 1,080 1,000 140 336
Fluoxetine 450 33 6 NA NA
Desipramine 2,217 1,680 250 3.9 NA
Clomipramine 2,670 7.1 NA NA NA
Amphetamine 10,800 3,180 20,000 56.1 881
Epinephrine 26,000 NA NA NA >1,000
Dopamine 42,000 >10,000 NA 139 316
Norepinephrine 79,000 NA NA NA >10,000
Final [3H]5HT concentrations were 100 nM, 50-100 nM, and 20 nM in determinations for dSERT1,
5HT transporter (5HTT), and human SERT1, respectively. Final [3H]norepinephrine concentration
was 20nM for NET1 and final [3H]dopamine concentration was 15 nM for dopamine transporter (DAT).
NA, not applicable.
*Hoffman et al. (13).
tRamamoorthy et al. (34).
tPacholczyk et al. (8).
§Giros et al. (12).
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FiG. 4. Ion and voltage dependence of SHT-induced inward
currents in oocytes expressing dSERT1. (A) Transport-associated
inward current for an oocyte voltage clamped at a holding potential
of -60 mV. The current was evoked with 10 ,AM SHT superfused in
ND96 medium for the time indicated by the bar above the trace. (B)
Steady-state currents, in the presence and absence of Na+ and Cl-
in the assay medium, plotted as a function of voltage for a second
oocyte. The 5HT concentiration was S pM.
a greater than linear increase in inward current with mem-
brane potential in the range of 0 to -80 mV. These electro-
physiological properties - of dSERT1 are similar to those
shown for the mamntalian GABA transporter GAT1 (42).
It is likely that, as in vertebrates, 5HT plays a range ofroles
in the fly, both as a classical neurotransmitter and as a
neuromodulator (35). Corpbined with the repertoire of avail-
able genetic tools for Drosophila, dSERT1 will be an impor-
tant reagent for further analysis of serotonergic neurons and
pathways, for isolation ofother insect Na+/Cl- transporters,
and for analyzing the structural basis of transporter function.
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